@article{HBSN14007,
author = {Ahmed Hammad and Toshimi Kaido and Yuhei Hamaguchi and Shinya Okumura and Atsushi Kobayashi and Hisaya Shirai and Naoko Kamo and Shintaro Yagi and Shinji Uemoto},
title = {Impact of sarcopenic overweight on the outcomes after living donor liver transplantation},
journal = {Hepatobiliary Surgery and Nutrition},
volume = {6},
number = {6},
year = {2017},
keywords = {},
abstract = {Background: The effect of body composition disturbances has been recently in focus. Sarcopenic obesity, a co-occurrence of low muscle mass and high body fat was reportedly predictive of high mortality in patients with cirrhosis. However, the impact of the interacting sarcopenia and overweight on the outcomes after liver transplantation is still unclear.
Methods: We evaluated 200 patients undergoing adult-to-adult living donor liver transplantation at our institution between January 2008 and November 2013 classified according to BMI and psoas muscle index (PMI) on admission to transplant into 4 subgroups; sarcopenic overweight (SO), sarcopenic non-overweight (SN), non-sarcopenic overweight and non-sarcopenic non-overweight (NN). Short-term outcomes and overall post-transplant survival were compared among the four subgroups.
Results: Sarcopenic patients with preoperative low PMI had higher incidence of postoperative bacteremia and major postoperative complications, and poorer overall post-transplant survival than non-sarcopenic patients with normal/high PMI (P},
issn = {2304-389X}, url = {https://hbsn.amegroups.org/article/view/14007}
}